Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: squetch who wrote (18878)	4/8/1998 9:03:00 AM
From: Henry Niman	Read Replies (1) of 32384

Stan, I think that there is a distinct limit on the amount of "experimenting" that they can do with patients. I suspect that when the start seeing "moderate" adverse effects, they consider that the maximum dose. On several of their protocols, this dose is patient specific (they gradually increase the dose until they start seeing side effects). I think that the "agressiveness" in increasing doses is somewhat dependent on the severity of the conditions. In terminal cancer patients, they are more aggressive in the dosing (I think that they go up to 600 mg).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next